Hultman, Bo <br/><br/>
Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Jan 2012 
 - 112-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2011.594809  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma--secondary<br/>Costs and Cost Analysis<br/>Digestive System Surgical Procedures--economics<br/>Female<br/>Humans<br/>Hyperthermia, Induced--economics<br/>Injections, Intraperitoneal<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--economics<br/>Peritoneal Neoplasms--secondary<br/>Stomach Neoplasms--pathology<br/>Treatment Outcome